<?xml-stylesheet type='text/xsl' href='ctgovTransform.xsl'?>
<CT.GOV_Trial requestNumber="1829">
  <stage>Registered</stage>
  <submitdate>11/02/2008</submitdate>
  <approvaldate>11/02/2008</approvaldate>
  <nctid>NCT00620529</nctid>
  <trial_identification>
    <studytitle>The Effects of Fish Oils on Blood Pressure, Heart Rate Variability and Liver Fat in the Polycystic Ovary Syndrome</studytitle>
    <scientifictitle>A Clinical Trial to Measure the Effect of DHA-enriched Fish Oils on Blood Pressure, Heart Rate Variability and Liver Fat Content in the Polycystic Ovary Syndrome</scientifictitle>
    <utrn />
    <trialacronym>fops</trialacronym>
    <secondaryid>EC 2008/049</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Polycystic Ovary Syndrome</healthcondition>
    <conditioncode>
      <conditioncode1>Other</conditioncode1>
      <conditioncode2>Research that is not of generic health relevance and not applicable to specific health categories listed above</conditioncode2>
    </conditioncode>
    <conditioncode>
      <conditioncode1>Reproductive Health and Childbirth</conditioncode1>
      <conditioncode2>Other reproductive health and childbirth disorders</conditioncode2>
    </conditioncode>
    <conditioncode>
      <conditioncode1>Metabolic and Endocrine</conditioncode1>
      <conditioncode2>Other endocrine disorders</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Other interventions - Ocean Nutrition 2050
Other interventions - Olive oil capsules

Experimental: 1 - 20/50 fish oil, 1000mg capsules, Ocean Nutrition 2050,4g/day.

Placebo Comparator: 2 - olive oil capsules


Other interventions: Ocean Nutrition 2050
1000mg capsules, 4 capsules/day for 8 weeks

Other interventions: Olive oil capsules
Olive oil capsules, 4 per day for 8 weeks

</interventions>
    <comparator />
    <control />
    <interventioncode>Other interventions interventions</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>24 hour ambulatory systolic blood pressure</outcome>
      <timepoint>week 8 and week 24</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>24 hour heart rate variability</outcome>
      <timepoint>week 8 and week 24</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>liver fat content (MRI)</outcome>
      <timepoint>week 8 and week 24</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>-  Overweight/obese women with PCOS as per 1990 NIH criteria (see below)

          -  Non-smokers

          -  Age&gt;18 years, premenopausal

          -  Acceptable to have/be on treatment for type 2 diabetes mellitus and/or dyslipidaemia

          -  Acceptable to be taking the oral contraceptive pill</inclusivecriteria>
    <inclusiveminage>18</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>50</inclusivemaxage>
    <inclusivemaxagetype>Years</inclusivemaxagetype>
    <inclusivegender>Female</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>-  Uncontrolled hypertension (BP&gt;160/100mmHg)

          -  Known co-morbidities including liver or renal disease

          -  Already taking fish oil supplements

          -  Other intercurrent illness (major surgery, CV event)

          -  Smokers

          -  Alcohol intake &gt;20g/day

          -  Pregnancy

          -  Any metallic implant (contraindication for MRI).</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment />
    <sequence />
    <masking>Blinded (masking used)</masking>
    <assignment>Crossover</assignment>
    <designfeatures />
    <endpoint />
    <statisticalmethods />
    <masking1>The people receiving the treatment/s</masking1>
    <masking2>The people administering the treatment/s</masking2>
    <masking3>The people assessing the outcomes</masking3>
    <masking4>The people analysing the results/data</masking4>
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Phase 4</phase>
    <anticipatedstartdate />
    <actualstartdate>1/02/2008</actualstartdate>
    <anticipatedenddate />
    <actualenddate />
    <samplesize>40</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Completed</recruitmentstatus>
    <anticipatedlastvisitdate />
    <actuallastvisitdate>1/02/2009</actuallastvisitdate>
    <dataanalysis />
    <withdrawnreason />
    <withdrawnreasonother />
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate>WA</recruitmentstate>
    <hospital>School of Medicine and Pharmacology, Royal Perth Hospital - Perth</hospital>
    <postcode>6000 - Perth</postcode>
  </recruitment>
  <sponsorship>
    <primarysponsortype>Other</primarysponsortype>
    <primarysponsorname>Keogh Institute for Medical Research</primarysponsorname>
    <primarysponsoraddress />
    <primarysponsorcountry />
    <othercollaborator>
      <othercollaboratortype>Other</othercollaboratortype>
      <othercollaboratorname>Royal Perth Hospital</othercollaboratorname>
      <othercollaboratoraddress />
      <othercollaboratorcountry />
    </othercollaborator>
  </sponsorship>
  <ethicsAndSummary>
    <summary>We hypothesise that fish oils will have a beneficial effect on cardiometabolic parameters in
      women with PCOS. The purpose of this study therefore is to examine the effects of fish oils
      on blood pressure, heart rate variability and liver fat content in obese women with the
      polycystic ovary syndrome.</summary>
    <trialwebsite>https://clinicaltrials.gov/show/NCT00620529</trialwebsite>
    <publication />
    <ethicsreview />
    <publicnotes />
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>Andrea J Cussons, MBBS</name>
      <address>The University of Western Australia</address>
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Public Queries</type>
    </contact>
  </contacts>
</CT.GOV_Trial>